Pular para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Tumour expression of the DNA r...
  • Citar
  • Enviar por SMS
  • Enviar por e-mail
  • Imprimir
  • Exportar registro
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Link permanente
Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Detalhes bibliográficos
Principais autores: Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR
Formato: Conference item
Publicado em: 2011
  • Itens
  • Descrição
  • Registros relacionados
  • Registro fonte

Registros relacionados

  • Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
    por: Gillies, R, et al.
    Publicado em: (2012)
  • Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
    por: Gillies, R, et al.
    Publicado em: (2012)
  • XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
    por: Hatch, S, et al.
    Publicado em: (2014)
  • Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
    por: Graf, Nora, et al.
    Publicado em: (2012)
  • Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
    por: MacGregor, T, et al.
    Publicado em: (2018)

Opções de Busca

  • Histórico de buscas
  • Busca Avançada

Encontrar Mais

  • Navegar o acervo
  • Navegar por ordem alfabética
  • Explorar canais
  • Bibliografia Recomendada
  • Novos itens

Precisa de ajuda?

  • Dicas de Busca
  • Serviço de Referência
  • Perguntas Frequentes